Skip to content

Research at St Andrews

Contribution by NRF2 upregulation to lung carcinogenesis, and the possible therapeutic value of NRF2 inhibition by GSK-3

Project: Standard

Participant(s)

Organisation(s)

Details

AcronymContribution by NRF2 upregulation
StatusActive
Effective start/end date1/05/1631/10/19
Funder Project ReferenceMR/N009851/1
FunderMedical Research Council
St Andrews funding£108,239.00

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

ID: 249118263